LAUREN SANDERSON: Open Payments
NPI 1205315009 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,369 in 64 payments from 13 companies in 2025. Trend: 2023 $1,806 · 2024 $1,526 · 2025 $1,369
Food & beverage: $1,369
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $456 |
| AstraZeneca Pharmaceuticals LP | 9 | $163 |
| Amgen Inc. | 10 | $163 |
| GlaxoSmithKline, LLC. | 6 | $109 |
| Novartis Pharmaceuticals Corporation | 5 | $103 |
| GENZYME CORPORATION | 2 | $93 |
| Janssen Biotech, Inc. | 4 | $80 |
| PFIZER INC. | 4 | $77 |
| ANI Pharmaceuticals, Inc. | 2 | $37 |
| UCB, Inc. | 1 | $27 |
Products named: RINVOQ, SAPHNELO, SKYRIZI, BENLYSTA, KEVZARA, XELJANZ, COSENTYX, TREMFYA.
Industry payments across MO — which companies pay providers there.
